IL-17A & IL-17F

IL-17A & IL-17F

IL-17A & IL-17F 詳細

Molecule Name
Interleukin-17F
分子の別称
IL-17A,Interleukin-17A,CTLA-8,IL-17,IL-17F,Interleukin-17F,Cytokine ML-1,IL17A&IL17F
Drug Development Progress
治験薬の数5
市販薬剤の数0
研究&開発段階NDA/BLA
ターゲットの別称
Cytokine ML-1,Interleukin-17F,IL17F,Interleukin 17F,IL-17F,CANDF6,ML-1,ML1
バックグランド
Interleukin-17A (IL17A) is also known as cytotoxic T-lymphocyte-associated antigen 8 (CTLA8),which is a proinflammatory cytokine produced by activated T cells. IL17A can regulate the activities of NF-kappaB and mitogen-activated protein kinases. Also,IL17A can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO).Furthermore,IL17A has been found both in glycosylated and nonglycosylated forms. High levels of IL-17 are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis.

IL-17A & IL-17F 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
SonelokimabALX-0761; MSB-0010841; M-1095Phase 3 ClinicalAblynx Nv
Arthritis, Psoriatic; Hidradenitis Suppurativa; Psoriasis
詳細
DMT-310DMT-310Phase 3 ClinicalDermata
Acne Vulgaris; Rosacea
詳細
ORKA-002ORKA-002; PR-029; ORKA-021Phase 2 ClinicalParagon Therapeutics Inc
Arthritis, Psoriatic; Plaque psoriasis; Psoriasis
詳細
PN-881PN-881Phase 1 ClinicalProtagonist Therapeutics Inc
Dermatitis; Psoriasis
詳細
HY-1770HY-1770; HT-17; HT17; YF02; HT25; GH02; HY1770Phase 1 ClinicalSuzhou Pharmavan Co Ltd
Dermatitis, Atopic; Plaque psoriasis
詳細